Renal Denervation: 60 Second Insights

Published: 22 March 2019

  • Views:

    Views Icon 8

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on renal denervation. Hear the expert views in under one minute!

More from this programme

Part 1

Thinking about patient preference, what role does RDN have in blood pressure control?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Part 2

What role do you see for renal denervation in control of blood pressure in your patients?

8 sessions
Justin Davies Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now
Patrick Serruys Watch now
Gerald Werner Watch now
Aloke Finn Watch now

Part 3

Where does renal denervation fit in your current clinical practice?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Part 4

What are the biggest barriers to blood pressure control in your patients?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Part 5

Which patient groups are most receptive to RDN?

7 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now
Gerald Werner Watch now

Part 6

What is needed to get widespread adoption into clinical practice?

7 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now
Gerald Werner Watch now

Part 7

How have SPYRAL HTN-OFF and SPYRAL HTN-ON studies influenced your clinical practice?

1 session
Justin Davies Watch now

Part 8

Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, what are the take-home messages for you?

1 session
Justin Davies Watch now

Part 9

Thinking about the SPYRAL HTN-OFF and SPYRAL HTN-ON studies, for you, what are the key results?

2 sessions
Justin Davies Watch now
David Kandzari Watch now

Part 10

Can you give an overview of the RDN SPYRAL clinical trial program?

2 sessions
Justin Davies Watch now
David Kandzari Watch now

Part 11

Thinking about compliance, what are the advantages of RDN over pharmacological therapy?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Part 12

How does renal denervation work?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Part 13

Does renal denervation work?

6 sessions
Justin Davies Watch now
Aloke Finn Watch now
David Kandzari Watch now
Horst Sievert Watch now
Ajay Kirtane Watch now
Robert Schwartz Watch now

Faculty Biographies

Horst Sievert

Horst Sievert

Director

Dr Horst Sievert, MD, is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology, and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. 

Dr Sievert is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt. Dr Sievert became Director of the Department of Interventional Cardiology and Angiology of the Heart Center Rotenburg in 1990, Senior Consultant at the Bethanien Hospital in Frankfurt in 1993, and Director of the CardioVascular Center Frankfurt, Sankt Katharinen in 2003. He has been the principal investigator in a number of clinical trials and has authored more than 130 manuscripts and 500 abstracts in peer-reviewed journals and 50 books and book contributions. 

View full profile